APYX
APYX
NASDAQ · Health Care

Apyx Medical Corp

$4.30
-0.36 (-7.73%)
As of Jul 4, 2:12 AM ET ·
Financial Highlights (FY 2026)
Revenue
53.89M
Net Income
-11,433,605
Gross Margin
62.5%
Profit Margin
-21.2%
Rev Growth
+5.9%
D/E Ratio
2.40
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.5% 62.5% 36.7% 36.7%
Operating Margin -12.2% -11.0% 18.0% 17.4%
Profit Margin -21.2% -20.2% 11.0% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 53.89M 50.90M 88.82M 91.82M
Gross Profit 33.70M 31.83M 32.57M 33.67M
Operating Income -6,575,153 -5,588,476 16.01M 15.98M
Net Income -11,433,605 -9,717,862 9.74M 12.10M
Gross Margin 62.5% 62.5% 36.7% 36.7%
Operating Margin -12.2% -11.0% 18.0% 17.4%
Profit Margin -21.2% -20.2% 11.0% 13.2%
Rev Growth +5.9% +5.9% -9.1% +17.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 63.60M 63.60M 11.75M 11.58M
Total Equity 26.51M 26.51M 90.85M 91.27M
D/E Ratio 2.40 2.40 0.13 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,905,407 -5,298,079 18.03M 21.54M
Free Cash Flow 4.63M 6.18M